Abstract: In this demo paper, we introduce SAPIEN, a platform for high-fidelity virtual agents driven by large language models that can hold open domain conversations with users in 13 different ...
The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...
Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and ...
The Sapien M3 heart valve is anchored in the heart with a catheter-delivered nitinol dock. [Image courtesy of Edwards Lifesciences] Edwards Lifesciences (NYSE: EW) + has won FDA approval for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback